Molecular Signature of Response to Pazopanib Salvage Therapy for Urothelial Carcinoma

Clin Genitourin Cancer. 2016 Feb;14(1):e81-90. doi: 10.1016/j.clgc.2015.07.017. Epub 2015 Aug 7.
No abstract available

Keywords: Advanced disease; Angiogenesis; Clinical benefit; Next-generation sequencing; Pazopanib.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inhibitors / pharmacology
  • Angiogenesis Inhibitors / therapeutic use*
  • Carcinoma, Transitional Cell / drug therapy
  • Carcinoma, Transitional Cell / genetics*
  • DNA Copy Number Variations
  • DNA Mutational Analysis
  • Drug Resistance, Neoplasm
  • Humans
  • Indazoles
  • Mutation, Missense
  • Pyrimidines / pharmacology
  • Pyrimidines / therapeutic use*
  • Salvage Therapy
  • Sulfonamides / pharmacology
  • Sulfonamides / therapeutic use*
  • Treatment Outcome
  • Urinary Bladder Neoplasms / drug therapy
  • Urinary Bladder Neoplasms / genetics*

Substances

  • Angiogenesis Inhibitors
  • Indazoles
  • Pyrimidines
  • Sulfonamides
  • pazopanib